Merck KGaA
MKGAF
$163.71
-$4.70-2.79%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 4.01% | 6.03% | 5.80% | 7.39% | 3.53% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.01% | 6.03% | 5.80% | 7.39% | 3.53% |
| Cost of Revenue | 2.39% | 5.64% | 5.71% | 5.49% | 10.87% |
| Gross Profit | 5.20% | 6.29% | 5.87% | 8.68% | -1.27% |
| SG&A Expenses | 6.65% | 11.70% | 12.13% | 10.11% | 5.02% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 36.33% | -141.09% | 79.00% | -220.46% | -58.98% |
| Total Operating Expenses | 7.89% | 6.75% | 17.20% | 4.51% | 0.93% |
| Operating Income | -14.99% | 2.88% | -27.25% | 18.36% | 18.47% |
| Income Before Tax | -22.35% | -0.89% | -45.94% | 14.50% | 11.35% |
| Income Tax Expenses | -15.60% | 0.09% | -39.94% | 3.58% | 1.93% |
| Earnings from Continuing Operations | -24.14% | -1.18% | -47.19% | 17.61% | 14.16% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -34.11% | -290.07% | -82.01% | 241.79% | -258.16% |
| Net Income | -24.41% | -2.21% | -47.77% | 18.57% | 13.26% |
| EBIT | -14.99% | 2.88% | -27.25% | 18.36% | 18.47% |
| EBITDA | -5.11% | 7.11% | -4.96% | 15.49% | 12.67% |
| EPS Basic | -24.22% | -1.92% | -47.77% | 18.35% | 12.97% |
| Normalized Basic EPS | -22.49% | -1.87% | -18.42% | 15.47% | 9.98% |
| EPS Diluted | -24.22% | -1.92% | -47.77% | 18.35% | 12.97% |
| Normalized Diluted EPS | -22.49% | -1.87% | -18.42% | 15.47% | 9.98% |
| Average Basic Shares Outstanding | -0.24% | -0.29% | 0.00% | 0.18% | 0.25% |
| Average Diluted Shares Outstanding | -0.24% | -0.29% | 0.00% | 0.18% | 0.25% |
| Dividend Per Share | -- | -- | 9.21% | -- | -- |
| Payout Ratio | 0.37% | -0.67% | -- | -- | -0.05% |